Medical Technology and Devices: from Lab to Patient
The EIC Transition Challenges 2021 program, "Medical Technology and Devices: from Lab to Patient", supports the advancement of novel medical technologies from early-stage research to clinical evaluation and market readiness. It aims to bridge the gap between groundbreaking scientific discoveries and their practical application for patient benefit. This program focuses on maturing existing proof-of-principle technologies and developing robust exploitation strategies to ensure market traction.
Who is Funded for Medical Technology and Devices?
The "Medical Technology and Devices: from Lab to Patient" program primarily funds a diverse range of entities, including small and medium-sized enterprises (SMEs) and research organizations, across EU Member States and Associated Countries. Its core objective is to translate cutting-edge medical research into tangible patient solutions, emphasizing both technological maturity and market potential.
What Medical Technologies are Funded?
The funding specifically targets the development of new medical technologies and devices, supporting projects from early research stages through to market readiness. While focusing on health-related innovations, the program also covers costs associated with advancing these technologies towards clinical application and commercialization.
Type and Scope of MedTech Funding
Financial support for medical technology projects is provided through grants, with a maximum contribution of up to 2.5 million euros per project. The typical project duration is set at up to three years, allowing sufficient time for technology maturation and exploitation strategy development.
Conditions and Requirements for EIC Transition Funding
Applicants and beneficiaries must adhere to specific conditions, including the requirement for proposals to build on prior eligible research projects and ownership of Intellectual Property Rights. Collaboration is encouraged, with options for single-entity or consortium applications. Financial guidelines and further details on eligibility and evaluation are outlined in the EIC Work Programme 2021 and related legal documents.
Application Procedure for Medical Technology Funding
The application process for this EIC Transition call involves a single-stage submission via the Funding & Tenders Portal, using a dedicated Standard Application Form. Evaluation and award criteria, along with timelines, are detailed in the EIC Work Programme 2021, guiding applicants through the selection process.
Legal Basis of the Funding Program
The "Medical Technology and Devices: from Lab to Patient" program operates under the robust legal framework of Horizon Europe, with its mandate rooted in official EU regulations and work programmes. Key legal texts and guidelines govern its implementation and financial management, ensuring transparency and compliance.
Similar Programs
Funding Overview
Funding Status:
Closed
Maximum Amount:
2,500,000 €
Award Channel:
Framework Programme Call
Region:
European Union and Associated Countries
Sectors:
Healthcare, Medical Technology, Research and Development, Information and Communication Technology
Beneficiaries:
Patients, Clinicians
Application Type:
Optional Consortium
Funding Stages:
Basic Research, Applied Research, Experimental Development, Prototyping, Pilot Testing, Commercialization, Market Introduction, Evaluation
Funding Provider
Program Level:
European Union
Funding Body:
European Commission
Managed By:
European Innovation Council (EIC)
Website: